Provided by Tiger Fintech (Singapore) Pte. Ltd.

Atara Biotherapeutics

7.80
+0.08001.04%
Post-market: 7.800.00000.00%18:14 EDT
Volume:20.12K
Turnover:156.55K
Market Cap:53.01M
PE:-0.68
High:8.02
Open:7.60
Low:7.54
Close:7.72
Loading ...
Dec 07, 2020

Major Issues Report

8-K - Current report
Nov 09, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 09, 2020

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Nov 09, 2020

Major Issues Report

8-K - Current report
Aug 05, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 05, 2020

Major Issues Report

8-K - Current report
Jun 19, 2020

Major Issues Report

8-K - Current report
May 28, 2020

Major Issues Report

8-K - Current report
May 12, 2020

Major Issues Report

8-K - Current report
May 06, 2020

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
May 06, 2020

Major Issues Report

Current report, items 2.02 and 9.01
Apr 30, 2020

Major Issues Report

Current report, item 5.02
Feb 27, 2020

Employee Stock Ownership

Securities to be offered to employees in employee benefit plans
Feb 27, 2020

Annual Report

Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 27, 2020

Major Issues Report

Current report, items 2.02 and 9.01
Feb 14, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 14, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 14, 2020

Beneficial Ownership Change

Statement of acquisition of beneficial ownership by individuals
Feb 13, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 12, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals